You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 104 No. 1, July 1971 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (22)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prolonged Oral Treatment of Chronic Mucocutaneous Candidiasis With Amphotericin B

Leopoldo F. Montes, MD, CRCP(C); Max D. Cooper, MD; Linwood G. Bradford, MD; Robert O. Lauderdale, MD; Clayton D. Taylor, MD

Arch Dermatol. 1971;104(1):45-56.


Abstract

Amphotericin B was given orally to four patients with chronic mucocutaneous candidiasis (CMCC) using a total daily dose of 1,000 to 1,800 mg. In one patient continuous treatment over a six-month period resulted in complete clearing of extensive candidal granuloma lesions. In another candidal granuloma patient a slower but continuous excellent response occurred. A hypothyroid patient and a patient with associated thymoma-myositis failed to respond. Higher antibiotic serum levels in the first two patients indicate significant individual variations in absorption may exist and probably account for the different results. The intracellular location of Candida albicans observed with the electron microscope suggests tissue levels were also, and perhaps more directly, involved in the therapeutic response. In view of this experience, and the lack of a nontoxic effective treatment, a more extensive oral trial of amphotericin B in CMCC seems fully justified.



Author Affiliations

Birmingham, Ala; Columbus, Ga

From the departments of dermatology (Drs. Montes, Bradford and Lauderdale), microbiology (Drs. Montes and Cooper), and pediatrics (Dr. Cooper), University of Alabama in Birmingham Medical Center. Dr. Taylor is in private practice in Columbus, Ga.


Footnotes

Accepted for publication Dec 5, 1970.

Reprint requests to 1919 Seventh Ave S, Birmingham, Ala 35233 (Dr. Montes).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Scanning Electron Microscopy of Oral Lesions in Chronic Mucocutaneous Candidiasis
Wilborn and Montes
JAMA 1980;244:2294-2297.
ABSTRACT  

Ketoconazole Treatment of Chronic Mucocutaneous Candidiasis
Graybill et al.
Arch Dermatol 1980;116:1137-1141.
ABSTRACT  

Chronic Mucocutaneous Candidiasis: Influence of Thyroid Status
Montes et al.
JAMA 1972;221:156-159.
ABSTRACT  

Chronic Mucocutaneous Candidiasis of the Adult: A Report of a Patient With an Associated Thymoma
Maize and Lynch
Arch Dermatol 1972;105:96-98.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.